Prediction of Alzheimer’s disease biomarker status defined by the ‘ATN framework’ among cognitively healthy individuals: results from the EPAD longitudinal cohort study by Catherine M. Calvin, Casper de Boer, Vanessa Raymont, John Gallacher, Ivan Koychev, The European Prevention of Alzheimer’s Dementia (EPAD) Consortium

Get full text

Prediction of Alzheimer's disease biomarker status defined by the ‘ATN Framework’ among cognitively healthy individuals: Results from the EPAD longitudinal cohort study by Calvin, C, Calvin, C, de Boer, C, Raymont, V, Gallacher, J, Koychev, I, The European Prevention of Alzheimer’s Dementia (EPAD) Consortium

Modifiable dementia risk factors and AT(N) biomarkers: findings from the EPAD cohort by Eddy Roccati, Aidan David Bindoff, Jessica Marie Collins, Joshua Eastgate, Jay Borchard, Jane Alty, Jane Alty, Anna Elizabeth King, James Clement Vickers, Margherita Carboni, Chad Logan, EPAD Consortium

Get full text

ADataViewer: exploring semantically harmonized Alzheimer’s disease cohort datasets by Yasamin Salimi, Daniel Domingo-Fernández, Carlos Bobis-Álvarez, Martin Hofmann-Apitius, Colin Birkenbihl, for the Alzheimer’s Disease Neuroimaging Initiative, the Japanese Alzheimer’s Disease Neuroimaging Initiative, for the Aging Brain: Vasculature, Ischemia, and Behavior Study, the Alzheimer’s Disease Repository Without Borders Investigators, for the European Prevention of Alzheimer’s Disease (EPAD) Consortium

Get full text